BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 28290816)

  • 21. Relationship between left ventricular wall thickness and left atrial size: comparison with other measures of diastolic function.
    Simek CL; Feldman MD; Haber HL; Wu CC; Jayaweera AR; Kaul S
    J Am Soc Echocardiogr; 1995; 8(1):37-47. PubMed ID: 7710749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy.
    Yasunari K; Maeda K; Watanabe T; Nakamura M; Yoshikawa J; Asada A
    J Am Coll Cardiol; 2004 Jun; 43(11):2116-23. PubMed ID: 15172423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect: evidence from the sample study.
    Omboni S; Fogari R; Palatini P; Rappelli A; Mancia G
    Hypertension; 1998 Sep; 32(3):424-9. PubMed ID: 9740606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy.
    Asmar R; Garcia-Puig J; Gosse P; Karpov YA; De Leeuws PW; Magometschniggs D; Matos L; Schmieder R
    Vasc Health Risk Manag; 2007; 3(4):371-80. PubMed ID: 17969366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of blood pressure variability to left ventricular function and arterial stiffness in hypertensive patients.
    Shin SH; Jang JH; Baek YS; Kwon SW; Park SD; Woo SI; Kim DH; Kwan J
    Singapore Med J; 2019 Aug; 60(8):427-431. PubMed ID: 30854570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.
    Nyström F; Malmqvist K; Ohman KP; Kahan T
    J Hypertens; 2002 Aug; 20(8):1527-33. PubMed ID: 12172314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure determinants of left ventricular wall thickness and mass index in hypertension: comparing office, ambulatory and exercise blood pressures.
    Lim PO; Donnan PT; MacDonald TM
    J Hum Hypertens; 2001 Sep; 15(9):627-33. PubMed ID: 11550109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure control in a hypertension hospital clinic.
    Cuspidi C; Lonati L; Sampieri L; Macca G; Valagussa L; Zaro T; Michev I; Salerno M; Leonetti G; Zanchetti A
    J Hypertens; 1999 Jun; 17(6):835-41. PubMed ID: 10459882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
    Takami T; Shigematsu M
    Clin Exp Hypertens; 2003 Nov; 25(8):525-35. PubMed ID: 14649310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
    Wachtell K; Bella JN; Rokkedal J; Palmieri V; Papademetriou V; Dahlöf B; Aalto T; Gerdts E; Devereux RB
    Circulation; 2002 Mar; 105(9):1071-6. PubMed ID: 11877357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of blood pressure control in left ventricular mass regression.
    Miller AB; Reichek N; St John Sutton M; Iyengar M; Henderson LS; Tarka EA; Bakris GL
    J Am Soc Hypertens; 2010; 4(6):302-10. PubMed ID: 20980215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular diastolic dyssynchrony in patients with treatment-naive hypertension and the effects of antihypertensive therapy.
    Kwon BJ; Lee SH; Park CS; Kim DB; Park HJ; Jang SW; Ihm SH; Youn HJ; Seung KB; Kim HY
    J Hypertens; 2015 Feb; 33(2):354-65. PubMed ID: 25333681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension.
    Fogari R; Zoppi A; Mugellini A; Tettamanti F; Lusardi P; Corradi L
    Eur Heart J; 1995 Aug; 16(8):1120-5. PubMed ID: 8665975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of hypertension and hypertension-related left ventricle hypertrophy on right ventricle function.
    Tumuklu MM; Erkorkmaz U; Ocal A
    Echocardiography; 2007 Apr; 24(4):374-84. PubMed ID: 17381646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study.
    Galderisi M; Lomoriello VS; Santoro A; Esposito R; Olibet M; Raia R; Di Minno MN; Guerra G; Mele D; Lombardi G
    J Am Soc Echocardiogr; 2010 Nov; 23(11):1190-8. PubMed ID: 20810245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors affecting left ventricular synchronicity in hypertensive patients: are arterial stiffness and central blood pressures influential?
    Kırış A; Kırış G; Karaman K; Sahin M; Gedikli O; Kaplan S; Orem A; Kutlu M; Kazaz Z
    Turk Kardiyol Dern Ars; 2012 Oct; 40(7):581-8. PubMed ID: 23363940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.
    Kim ED; Sozio SM; Estrella MM; Jaar BG; Shafi T; Meoni LA; Kao WH; Lima JA; Parekh RS
    BMC Nephrol; 2015 Aug; 16():131. PubMed ID: 26249016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of spironolactone on vascular, myocardial, and functional parameters in untreated patients with a hypertensive response to exercise.
    Hare JL; Sharman JE; Leano R; Jenkins C; Wright L; Marwick TH
    Am J Hypertens; 2013 May; 26(5):691-9. PubMed ID: 23412930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.